Avoro Calls Merck's $180/sh Offer for Acceleron Pharma (XLRN) Inadequate; Urges Shareholders Not to Tender
Go back to Avoro Calls Merck's $180/sh Offer for Acceleron Pharma (XLRN) Inadequate; Urges Shareholders Not to Tender| Merck & Co. (NYSE: MRK) | Delayed: 119.60 +4.12 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.48 | 52 Week High | $65.46 | |||
| Open | $116.53 | 52 Week Low | $47.97 | |||
| Day High | $119.80 | P/E | 81.36 | |||
| Day Low | $116.53 | EPS | $1.47 | |||
| Volume | 11,893,949 | |||||
| ACCELERON PHARMA (NASDAQ: XLRN) | Delayed: 178.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.75 | 52 Week High | $50.86 | |||
| Open | $178.75 | 52 Week Low | $22.67 | |||
| Day High | $178.75 | P/E | 16.93 | |||
| Day Low | $178.75 | EPS | $10.56 | |||
| Volume | 158,297 | |||||
